Login to Your Account

FKD Secures Expertise for Gene Therapy Phase II Trial

By Nuala Moran
Staff Writer

Wednesday, August 1, 2012
LONDON – FKD Therapies Oy has secured the support of the leading urologic oncologists in the U.S. for the Phase II trial of Instiladrin, a gene therapy treatment for bladder cancer.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription